EUVIMEDEUVIMED entdecken
Übersichtsarbeit

RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations

Annemieke Smit-van Oosten, Coen A Stegeman, Harry van Goor

Current Drug Target -Cardiovascular & Hematological Disorders · 2003

DOI: 10.2174/1568006033337258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -Cardiovascular & Hematological Disorders, 2003. Verfasst von Annemieke Smit-van Oosten und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University Hospital Groningen, The Netherlands. a.smit-van.oosten@med.rug.nl. Hauptthemen laut MEDLINE: Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalAngiotensin-Converting Enzyme InhibitorsAnimalsGraft RejectionHumansKidney TransplantationRenin-Angiotensin System

Substanzen

Angiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University Hospital Groningen, The Netherlands. a.smit-van.oosten@med.rug.nl

Zitieren

APA

Smit-van Oosten, A., Stegeman, C. A., & van Goor, H. (2003). RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations. Current Drug Target -Cardiovascular & Hematological Disorders. https://doi.org/10.2174/1568006033337258

Vancouver

Smit-van Oosten A, Stegeman CA, van Goor H. RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations. Current Drug Target -Cardiovascular & Hematological Disorders. 2003. doi:10.2174/1568006033337258

BibTeX
@article{SmitvanOosten2003,
  author = {Smit-van Oosten, Annemieke and Stegeman, Coen A and van Goor, Harry},
  title = {RAS Blockade in Experimental Renal Transplantation. Benefits and Limitations},
  journal = {Current Drug Target -Cardiovascular & Hematological Disorders},
  year = {2003},
  doi = {10.2174/1568006033337258}
}
Kostenlos starten →